Clinical Trial Update: Effect of Liraglutide on Body Weight in Non-diabetic Obese Subjects or Overweight Subjects With Co-morbidities: SCALE™ - Obesity and Pre-diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating liraglutide for weight loss in non-diabetic obese or overweight individuals with co-morbidities; results completed with posted result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 3 | Status: COMPLETED | Results posted: 2015-02-09